Item Type | Name |
Academic Article
|
Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavir.
|
Academic Article
|
The cellular pharmacology of nucleoside- and nucleotide-analogue reverse-transcriptase inhibitors and its relationship to clinical toxicities.
|
Academic Article
|
Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: a pilot study.
|
Academic Article
|
The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients.
|
Academic Article
|
Concentrations of zidovudine- and lamivudine-triphosphate according to cell type in HIV-seronegative adults.
|
Academic Article
|
Cytokine and sex hormone effects on zidovudine- and lamivudine-triphosphate concentrations in vitro.
|
Academic Article
|
Pharmacokinetics of concurrent administration of fosamprenavir and atazanavir without ritonavir in human immunodeficiency virus-negative subjects.
|
Academic Article
|
Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors.
|
Academic Article
|
Effect of antacids on the pharmacokinetics of raltegravir in human immunodeficiency virus-seronegative volunteers.
|
Academic Article
|
Atazanavir metabolism according to CYP3A5 status: an in vitro-in vivo assessment.
|
Academic Article
|
Concentration-controlled compared with conventional antiretroviral therapy for HIV infection.
|
Academic Article
|
Review and management of drug interactions with boceprevir and telaprevir.
|
Academic Article
|
Therapeutic drug monitoring: pharmacologic considerations for antiretroviral drugs.
|
Academic Article
|
Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals.
|
Academic Article
|
Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients.
|
Academic Article
|
Antiretroviral medication adherence and the development of class-specific antiretroviral resistance.
|
Academic Article
|
Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection.
|
Academic Article
|
Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure.
|
Academic Article
|
Influence of SLCO1B1 polymorphisms on the drug-drug interaction between darunavir/ritonavir and pravastatin.
|
Academic Article
|
Effect of HIV-1 infection and sex on the cellular pharmacology of the antiretroviral drugs zidovudine and lamivudine.
|
Academic Article
|
A population pharmacokinetic-pharmacogenetic analysis of atazanavir.
|
Concept
|
Genitalia, Female
|
Concept
|
Contraceptive Devices, Female
|
Concept
|
Female
|
Academic Article
|
Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP).
|
Academic Article
|
Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detection.
|
Academic Article
|
Cefoxitin continuous infusion for lung infection caused by the Mycobacterium abscessus group.
|
Academic Article
|
A practical method to measure GFR in people with type 1 diabetes.
|
Academic Article
|
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.
|
Academic Article
|
HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial.
|
Academic Article
|
Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study.
|
Academic Article
|
Population pharmacokinetic modeling of plasma and intracellular ribavirin concentrations in patients with chronic hepatitis C virus infection.
|
Academic Article
|
Reduced immune activation during tenofovir-emtricitabine therapy in HIV-negative individuals.
|
Academic Article
|
Short communication: Tenofovir diphosphate in dried blood spots as an objective measure of adherence in HIV-infected women.
|
Academic Article
|
Accuracy of Electronic Medical Record Medication Reconciliation in Emergency Department Patients.
|
Academic Article
|
Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial.
|
Academic Article
|
Relationship Between Genital Drug Concentrations and Cervical Cellular Immune Activation and Reconstitution in HIV-1-Infected Women on a Raltegravir Versus a Boosted Atazanavir Regimen.
|
Academic Article
|
Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring.
|
Academic Article
|
Nondaily preexposure prophylaxis for HIV prevention.
|
Academic Article
|
Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066).
|
Academic Article
|
Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.
|
Academic Article
|
A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring.
|
Academic Article
|
Measuring glomerular filtration rate by iohexol clearance on filter paper is feasible in adolescents with type 1 diabetes in the ambulatory setting.
|
Academic Article
|
Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342).
|
Academic Article
|
Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women.
|
Academic Article
|
Intracellular Tenofovir and Emtricitabine Anabolites in Genital, Rectal, and Blood Compartments from First Dose to Steady State.
|
Academic Article
|
Analysis of the Endogenous Deoxynucleoside Triphosphate Pool in HIV-Positive and -Negative Individuals Receiving Tenofovir-Emtricitabine.
|
Academic Article
|
Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.
|
Academic Article
|
Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside Triphosphates.
|
Academic Article
|
Characterization of HIV Seroconverters in a TDF/FTC PrEP Study: HPTN 067/ADAPT.
|
Academic Article
|
High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project.
|
Academic Article
|
Brief Report: Recovery of Bone Mineral Density After Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis.
|
Academic Article
|
Medication adherence, condom use and sexually transmitted infections in Australian preexposure prophylaxis users.
|
Academic Article
|
Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomen.
|
Academic Article
|
Plasma Tenofovir Levels to Support Adherence to TDF/FTC Preexposure Prophylaxis for HIV Prevention in MSM in Los Angeles, California.
|
Academic Article
|
Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial.
|
Academic Article
|
Changes in Kidney Function Associated With Daily Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Preexposure Prophylaxis Use in the United States Demonstration Project.
|
Academic Article
|
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy.
|
Academic Article
|
Metabolic Effects of Preexposure Prophylaxis With Coformulated Tenofovir Disoproxil Fumarate and Emtricitabine.
|
Academic Article
|
Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study.
|
Academic Article
|
Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
|
Academic Article
|
Pharmacokinetic and Pharmacodynamic Properties of Metronidazole in Pediatric Patients With Acute Appendicitis: A Prospective Study.
|
Academic Article
|
CYP2D6 Genotype Phenotype Discordance Due to Drug-Drug Interaction.
|
Academic Article
|
Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis.
|
Academic Article
|
Short Communication: Bioequivalence of Tenofovir and Emtricitabine After Coencapsulation with the Proteus Ingestible Sensor.
|
Academic Article
|
Cryopreservation of human mucosal tissues.
|
Academic Article
|
Can We Improve Stavudine's Safety Profile in Children? Pharmacokinetics of Intracellular Stavudine Triphosphate with Reduced Dosing.
|
Academic Article
|
Tenofovir Diphosphate in Dried Blood Spots Is Strongly Associated With Viral Suppression in Individuals With Human Immunodeficiency Virus Infections.
|
Academic Article
|
Similar tenofovir hair concentrations in men and women after directly observed dosing of tenofovir disoproxil fumarate/emtricitabine: implications for preexposure prophylaxis adherence monitoring.
|
Academic Article
|
Randomized Controlled Trial of a Mobile Health Intervention to Promote Retention and Adherence to Preexposure Prophylaxis Among Young People at Risk for Human Immunodeficiency Virus: The EPIC Study.
|
Academic Article
|
Phase 1 Pharmacokinetic Trial of 2 Intravaginal Rings Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048.
|
Academic Article
|
Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings.
|
Academic Article
|
Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men1.
|
Academic Article
|
Emtricitabine triphosphate in dried blood spots is a predictor of viral suppression in HIV infection and reflects short-term adherence to antiretroviral therapy.
|
Academic Article
|
Engagement in Mental Health Care is Associated with Higher Cumulative Drug Exposure and Adherence to Antiretroviral Therapy.
|
Academic Article
|
Predictive Value of Tenofovir Diphosphate in Dried Blood Spots for Future Viremia in Persons Living With HIV.
|
Academic Article
|
Increased tenofovir monoester concentrations in patients receiving tenofovir disoproxil fumarate with ledipasvir/sofosbuvir.
|
Academic Article
|
Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarate.
|
Academic Article
|
Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing.
|
Academic Article
|
Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project.
|
Academic Article
|
Tenofovir disoproxil fumarate intravaginal ring for HIV pre-exposure prophylaxis in sexually active women: a phase 1, single-blind, randomised, controlled trial.
|
Academic Article
|
Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study.
|
Academic Article
|
Moderately High Tenofovir Diphosphate in Dried Blood Spots Indicates Drug Resistance in Viremic Persons Living with HIV.
|
Academic Article
|
Frequency and Predictors of Tenofovir-diphosphate Detection Among Young Kenyan Women in a Real-world Pre-exposure Prophylaxis Implementation Program.
|
Academic Article
|
Failure of pre-exposure prophylaxis with daily tenofovir/emtricitabine and the scenario of delayed HIV seroconversion.
|
Academic Article
|
Factors associated with tenofovir diphosphate concentrations in dried blood spots in persons living with HIV.
|
Academic Article
|
Pharmacology and drug interactions with HIV PrEP in transgender persons receiving gender affirming hormone therapy.
|
Academic Article
|
Approaches to Objectively Measure Antiretroviral Medication Adherence and Drive Adherence Interventions.
|
Academic Article
|
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study.
|
Academic Article
|
HIV Pre-Exposure Prophylaxis for Conception Among HIV Serodiscordant Couples in the United States: A Cohort Study.
|
Academic Article
|
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
|
Academic Article
|
Sex Hormone Therapy and Tenofovir Diphosphate Concentration in Dried Blood Spots: Primary Results of the Interactions Between Antiretrovirals And Transgender Hormones Study.
|
Academic Article
|
Randomized Pilot Study of an Advanced Smart-Pill Bottle as an Adherence Intervention in Patients With HIV on Antiretroviral Treatment.
|
Academic Article
|
Lower Cumulative Antiretroviral Exposure in People Living With HIV and Diabetes Mellitus.
|
Academic Article
|
Individualized Adherence Benchmarks for HIV Pre-Exposure Prophylaxis.
|
Academic Article
|
Tenofovir Diphosphate Concentrations in Dried Blood Spots From Pregnant and Postpartum Adolescent and Young Women Receiving Daily Observed Pre-exposure Prophylaxis in Sub-Saharan Africa.
|
Academic Article
|
Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody.
|
Academic Article
|
HIV Prevention and Treatment Cascades Among Female Sex Workers in Benin, West Africa.
|
Academic Article
|
Effect of SMS reminders on PrEP adherence in young Kenyan women (MPYA study): a randomised controlled trial.
|
Academic Article
|
Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis.
|
Academic Article
|
Results from a Pre-exposure Prophylaxis Demonstration Project for At-risk Cisgender Women in the United States.
|
Academic Article
|
A comparison of covariate selection techniques applied to pre-exposure prophylaxis (PrEP) drug concentration data in men and transgender women at risk for HIV.
|
Academic Article
|
Using the adherence-efficacy relationship of emtricitabine and tenofovir disoproxil fumarate to calculate background hiv incidence: a secondary analysis of a randomized, controlled trial.
|
Academic Article
|
PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial.
|
Academic Article
|
Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre-exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled trial.
|
Academic Article
|
Estimated pill intake with on-demand PrEP with oral TDF/FTC using TFV-DP concentration in dried blood spots in the ANRS IPERGAY trial.
|
Academic Article
|
Tenofovir Diphosphate in Dried Blood Spots in Pregnant and Postpartum Women With HIV in Kenya: A Novel Approach to Measuring Peripartum Adherence.
|
Academic Article
|
Tenofovir diphosphate levels in dried blood spots are associated with virologic failure and resistance to first-line therapy in South Africa: a case-control cohort study.
|
Academic Article
|
Understanding Pre-Exposure Prophylaxis Adherence in Young Women in Kenya.
|
Academic Article
|
Tenofovir diphosphate in dried blood spots predicts future viremia in persons with HIV taking antiretroviral therapy in South Africa.
|
Academic Article
|
Predictors of 007 triphosphate concentrations in dried blood spots in persons with hepatitis C and active drug or alcohol use.
|
Academic Article
|
Genital Inflammation Is Not Associated With Decreased Vaginal Tenofovir Concentrations in Women Taking Oral PrEP.
|
Academic Article
|
Adherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical Setting.
|
Academic Article
|
European longitudinal study on the relationship between adolescents' alcohol marketing exposure and alcohol use.
|
Academic Article
|
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma.
|
Academic Article
|
Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas study.
|
Academic Article
|
Poor sleep and lower working memory in grade 1 children: cross-sectional, population-based study.
|
Academic Article
|
Novel treatment for desmoplastic small round cell tumor: hyperthermic intraperitoneal perfusion.
|
Academic Article
|
Delivery of Brief Interventions for Heavy Drinking in Primary Care: Outcomes of the ODHIN 5-Country Cluster Randomized Trial.
|
Academic Article
|
Early lymphocyte recovery as a prognostic indicator for high-risk Ewing sarcoma.
|
Academic Article
|
Schooling duration rather than chronological age predicts working memory between 6 and 7 years: Memory Maestros Study.
|
Academic Article
|
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.
|
Academic Article
|
A Mixed-Methods Study Examining Adherence to and Acceptability of Intravaginal Rings for HIV Prevention: Behavioral Results of MTN-027.
|
Academic Article
|
Perceived appropriateness of alcohol screening and brief advice programmes in Colombia, Mexico and Peru and barriers to their implementation in primary health care - a cross-sectional survey.
|
Academic Article
|
Utility of Different Adherence Measures for PrEP: Patterns and Incremental Value.
|
Academic Article
|
Extreme prematurity, growth and neurodevelopment at 8 years: a cohort study.
|
Academic Article
|
Derivation and Initial Validation of Clinical Phenotypes of Children Presenting with Concussion Acutely in the Emergency Department: Latent Class Analysis of a Multi-Center, Prospective Cohort, Observational Study.
|
Academic Article
|
Transplacental transmission of bluetongue virus 8 in cattle, UK.
|
Academic Article
|
Self-reported Recent PrEP Dosing and Drug Detection in an Open Label PrEP Study.
|
Academic Article
|
Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084.
|
Academic Article
|
Breast cancer risk is not increased in individuals with TWIST1 mutation confirmed Saethre-Chotzen syndrome: an Australian multicenter study.
|
Academic Article
|
Multiplex PCR-based reverse line blot assay for simultaneous detection of 22 virulence genes in uropathogenic Escherichia coli.
|
Academic Article
|
Prevalence of and potential influencing factors for alcohol dependence in Europe.
|
Academic Article
|
A multicountry controlled trial of strategies to promote dissemination and implementation of brief alcohol intervention in primary health care: findings of a World Health Organization collaborative study.
|
Academic Article
|
Unusual response characteristics of pheromone-specific olfactory receptor neurons in the Asian corn borer moth, Ostrinia furnacalis.
|
Academic Article
|
Implementing referral to an electronic alcohol brief advice website in primary healthcare: results from the ODHIN implementation trial.
|
Academic Article
|
Study protocol: Asking QUestions about Alcohol in pregnancy (AQUA): a longitudinal cohort study of fetal effects of low to moderate alcohol exposure.
|
Academic Article
|
Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083.
|
Academic Article
|
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
|
Academic Article
|
Characterizing HIV-Preventive, Plasma Tenofovir Concentrations-A Pooled Participant-level Data Analysis From Human Immunodeficiency Virus Preexposure Prophylaxis Clinical Trials.
|
Academic Article
|
The occurrence of Blastocystis hominis in HIV-infected patients.
|
Academic Article
|
Intimate partner violence and oral HIV pre-exposure prophylaxis adherence among young African women.
|
Academic Article
|
Multiple Site SBRT in Pediatric, Adolescent, and Young Adult Patients With Recurrent and/or Metastatic Sarcoma.
|
Academic Article
|
PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project.
|
Academic Article
|
Gender-Affirming Hormone Pharmacokinetics Among Adolescent and Young Adult Transgender Persons Receiving Daily Emtricitabine/Tenofovir Disoproxil Fumarate.
|
Academic Article
|
Impact of feminizing hormone therapy on tenofovir and emtricitabine plasma pharmacokinetics: a nested drug-drug interaction study in a cohort of Brazilian transgender women using HIV pre-exposure prophylaxis.
|
Academic Article
|
Pharmacokinetics of Emtricitabine/Tenofovir Disoproxil Fumarate Among Transgender Adolescents and Young Adults Without HIV Receiving Gender Affirming Hormones.
|
Academic Article
|
Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial.
|
Academic Article
|
Association between prenatal maternal anxiety and/or stress and offspring's cognitive functioning: A meta-analysis.
|
Academic Article
|
Randomized Trial of Individualized Texting for Adherence Building (iTAB) Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals: The iM-PrEPT Study.
|
Academic Article
|
Updating the Adherence-Response for Oral Emtricitabine/Tenofovir Disoproxil Fumarate for Human Immunodeficiency Virus Pre-Exposure Prophylaxis Among Cisgender Women.
|
Academic Article
|
High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study.
|
Academic Article
|
Development of a tool to assess HIV prevention readiness of adolescent girls and young women in HPTN 082 study.
|
Academic Article
|
Comparing Predictive Ability of Two Objective Adherence Measures in a Community-Based Cohort on Antiretroviral Therapy in South Africa: Tenofovir Diphosphate Concentrations and Electronic Adherence Monitors.
|
Academic Article
|
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083.
|
Academic Article
|
Health-related quality of life in adults born extremely preterm or with extremely low birth weight in the postsurfactant era: a longitudinal cohort study.
|
Academic Article
|
Alcohol, tobacco and health care costs: a population-wide cohort study (n = 606 947 patients) of current drinkers based on medical and administrative health records from Catalonia.
|
Academic Article
|
Trust in the provider and accurate self-reported PrEP adherence among adolescent girls and young women in South Africa and Zimbabwe: HPTN 082 study.
|
Academic Article
|
A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir.
|
Academic Article
|
Performance of Multiple Adherence Measures for pre-exposure Prophylaxis (PrEP) Among Young Women in Kenya.
|
Academic Article
|
Long-acting refillable nanofluidic implant confers protection against SHIV infection in nonhuman primates.
|
Academic Article
|
HIV pre-exposure prophylaxis initiation, persistence, and adherence during pregnancy through the postpartum period.
|
Academic Article
|
Estradiol and Spironolactone Plasma Pharmacokinetics Among Brazilian Transgender Women Using HIV Pre-Exposure Prophylaxis: Analysis of Potential Interactions.
|
Academic Article
|
Tenofovir diphosphate in dried blood spots and HIV-1 resistance in South Africa.
|
Academic Article
|
Clinical Risk Score for Persistent Postconcussion Symptoms Among Children With Acute Concussion in the ED.
|
Academic Article
|
Efficacy estimates of oral pre-exposure prophylaxis for HIV prevention in cisgender women with partial adherence.
|
Academic Article
|
A simple screen performed at school entry can predict academic under-achievement at age seven in children born very preterm.
|
Academic Article
|
Association of tenofovir diphosphate and lamivudine triphosphate concentrations with HIV and hepatitis B virus viral suppression.
|
Academic Article
|
Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial.
|
Academic Article
|
Viral and host mediators of non-suppressible HIV-1 viremia.
|
Academic Article
|
Differential impact of minimum unit pricing on alcohol consumption between Scottish men and women: controlled interrupted time series analysis.
|
Academic Article
|
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial.
|
Academic Article
|
Impact of COVID-19 Confinement on Alcohol Purchases in Great Britain: Controlled Interrupted Time-Series Analysis During the First Half of 2020 Compared With 2015-2018.
|